InnoBrain

InnoBrain operates in the Medical Device and Neuroscience categories, with a neurotechnology focus on brain-computer interfaces and cognitive monitoring. Its described offering combines EEG signal interpretation, AI-based analysis, and a cloud platform intended to provide insights into cognitive states. The company also describes support for a range of EEG headsets through Lab Streaming Layer or device SDK integrations, which could reduce dependence on a single hardware provider. Its stated use cases center on monitoring and potentially improving safety, performance, and responsiveness in organizational settings. No distinct competitor can be identified from the available company information, so a direct comparison of product scope, pricing, clinical validation, or market share is not possible. The company’s differentiators are therefore best understood as its stated technical approach—neuroscience-led BCI analysis, real-time feedback, and hardware-agnostic EEG connectivity—rather than demonstrated advantages over named rivals. Its small reported employee band and single disclosed venture round suggest an early-stage profile, though the amount and current commercial footprint are unknown.

InnoBrain’s recorded timeline points to an early-stage company with a small disclosed operating footprint. The company was founded in 2019, after its two co-founders, Mohammad Davari and Masih Davari, began their listed roles in February 2017. The company is classified in the 1–10 employee range, and two current positions are listed, including Davari’s Co-Founder role and Masih Davari’s Co-Founder and Design Lead role. Its product direction centers on AI-based analysis of EEG signals, real-time cognitive-state monitoring, and cloud delivery, with integrations designed for compatible EEG headsets.